Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $15,767 | 833 | 54.0% |
| Consulting Fee | $8,720 | 2 | 29.9% |
| Unspecified | $1,979 | 3 | 6.8% |
| Travel and Lodging | $1,613 | 11 | 5.5% |
| Education | $1,110 | 15 | 3.8% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $7,476 | 46 | $0 (2024) |
| UCB, Inc. | $3,546 | 28 | $0 (2024) |
| Regeneron Pharmaceuticals, Inc. | $1,979 | 3 | $0 (2017) |
| ABBVIE INC. | $1,958 | 102 | $0 (2024) |
| Janssen Biotech, Inc. | $1,885 | 85 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,344 | 98 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $1,301 | 67 | $0 (2024) |
| Eli Lilly and Company | $1,127 | 8 | $0 (2017) |
| LEO Pharma Inc. | $1,011 | 62 | $0 (2024) |
| PFIZER INC. | $934.38 | 46 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,222 | 113 | ABBVIE INC. ($308.42) |
| 2023 | $4,451 | 225 | Janssen Biotech, Inc. ($728.06) |
| 2022 | $2,810 | 150 | ABBVIE INC. ($473.67) |
| 2021 | $1,612 | 105 | AbbVie Inc. ($288.72) |
| 2020 | $890.25 | 48 | Sun Pharmaceutical Industries Inc. ($203.81) |
| 2019 | $7,895 | 83 | GENZYME CORPORATION ($6,558) |
| 2018 | $4,512 | 72 | UCB, Inc. ($3,144) |
| 2017 | $4,797 | 68 | Regeneron Pharmaceuticals, Inc. ($1,979) |
All Payment Transactions
864 individual payment records from CMS Open Payments — Page 1 of 35
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $27.16 | General |
| Category: Dermatology | ||||||
| 12/19/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: DERMATOLOGY | ||||||
| 12/19/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $4.62 | General |
| Category: DERMATOLOGY | ||||||
| 12/18/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $25.96 | General |
| Category: Dermatology | ||||||
| 12/17/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $27.83 | General |
| Category: DERMATOLOGY | ||||||
| 12/17/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $24.36 | General |
| Category: IMMUNOLOGY | ||||||
| 12/17/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: Immunology | ||||||
| 12/12/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $28.93 | General |
| Category: DERMATOLOGY | ||||||
| 12/11/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: Dermatology | ||||||
| 12/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $9.22 | General |
| Category: Immunology | ||||||
| 12/11/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $7.35 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $40.38 | General |
| Category: Immunology | ||||||
| 12/05/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $20.13 | General |
| Category: Dermatology | ||||||
| 12/04/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $32.80 | General |
| Category: DERMATOLOGY | ||||||
| 12/04/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $6.36 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $52.43 | General |
| Category: Dermatology | ||||||
| 11/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $34.71 | General |
| Category: IMMUNOLOGY | ||||||
| 11/22/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $5.99 | General |
| Category: DERMATOLOGY | ||||||
| 11/21/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $38.72 | General |
| Category: DERMATOLOGY | ||||||
| 11/21/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $24.66 | General |
| Category: Dermatology | ||||||
| 11/21/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $3.38 | General |
| Category: DERMATOLOGY | ||||||
| 11/20/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $13.71 | General |
| Category: Dermatology | ||||||
| 11/15/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $8.49 | General |
| Category: Immunology | ||||||
| 11/14/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $2.52 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: Immunology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| An Open-label, Randomized, Actual Use Study of Dupilumab Auto-injector Device in Patients With Atopic Dermatitis | Regeneron Pharmaceuticals, Inc. | $1,979 | 3 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 1,405 | 2,095 | $557,649 | $131,769 |
| 2022 | 13 | 1,350 | 2,030 | $521,579 | $123,798 |
| 2021 | 11 | 1,176 | 1,611 | $465,593 | $122,181 |
| 2020 | 11 | 952 | 1,470 | $237,838 | $76,857 |
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 415 | 558 | $165,726 | $38,506 | 23.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 179 | 265 | $111,300 | $27,021 | 24.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 230 | 274 | $103,572 | $26,688 | 25.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 142 | 142 | $52,398 | $10,936 | 20.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 140 | 185 | $41,255 | $8,304 | 20.1% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 91 | 99 | $33,462 | $7,837 | 23.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 23 | 23 | $12,581 | $3,079 | 24.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 56 | 63 | $11,718 | $2,829 | 24.1% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 91 | 444 | $10,212 | $2,661 | 26.1% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2023 | 11 | 15 | $6,615 | $1,767 | 26.7% |
| 10040 | Acne surgery | Office | 2023 | 16 | 16 | $6,192 | $1,415 | 22.9% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 11 | 11 | $2,618 | $725.67 | 27.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 367 | 483 | $142,485 | $34,746 | 24.4% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 226 | 277 | $103,598 | $27,224 | 26.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 195 | 277 | $115,232 | $25,745 | 22.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 134 | 134 | $48,910 | $10,656 | 21.8% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 145 | 179 | $39,559 | $7,773 | 19.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 74 | 83 | $28,054 | $6,498 | 23.2% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 109 | 479 | $11,017 | $3,020 | 27.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 19 | 19 | $10,317 | $2,270 | 22.0% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2022 | 15 | 17 | $7,429 | $1,998 | 26.9% |
| 10060 | Simple or single drainage of skin abscess | Office | 2022 | 13 | 15 | $6,135 | $1,473 | 24.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 27 | 28 | $5,152 | $1,431 | 27.8% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 15 | 19 | $3,211 | $944.72 | 29.4% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 11 | 20 | $480.00 | $18.71 | 3.9% |
About Dr. Janet Lin, MD
Dr. Janet Lin, MD is a Dermatology healthcare provider based in Baltimore, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/03/2008. The National Provider Identifier (NPI) number assigned to this provider is 1356500524.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Janet Lin, MD has received a total of $29,189 in payments from pharmaceutical and medical device companies, with $2,222 received in 2024. These payments were reported across 864 transactions from 44 companies. The most common payment nature is "Food and Beverage" ($15,767).
As a Medicare-enrolled provider, Lin has provided services to 4,883 Medicare beneficiaries, totaling 7,206 services with total Medicare billing of $454,604. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Baltimore, MD
- Active Since 06/03/2008
- Last Updated 11/06/2014
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1356500524
Products in Payments
- DUPIXENT (Drug) $6,812
- DUPIXENT DUPILUMAB INJECTION (Biological) $2,041
- TREMFYA (Drug) $1,510
- SKYRIZI (Biological) $979.44
- DUPIXENT (Biological) $940.97
- EUCRISA (Drug) $852.61
- COSENTYX (Biological) $741.25
- VTAMA (Drug) $649.40
- ADBRY (Biological) $606.40
- COSENTYX (Drug) $586.60
- TALTZ (Drug) $544.31
- RINVOQ (Biological) $465.85
- Sotyktu (Drug) $443.13
- OPZELURA (Drug) $412.09
- ENSTILAR (Drug) $350.26
- Humira (Biological) $349.56
- Cimzia (Drug) $342.18
- Otezla (Drug) $315.20
- Hylatopic (Drug) $303.67
- Tremfya (Drug) $265.31
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Baltimore
Dr. Tamia Harris-Tryon, M.d.,Ph.d, M.D.,PH.D
Dermatology — Payments: $130,558
Crystal Aguh, M.d, M.D
Dermatology — Payments: $102,856
Elizabeth Tanzi, M.d, M.D
Dermatology — Payments: $63,577
Sewon Kang, Md, MD
Dermatology — Payments: $32,719
Dr. Anthony Gaspari, M.d, M.D
Dermatology — Payments: $31,010
Dr. Larry Gaston, M.d, M.D
Dermatology — Payments: $29,682